4/16
12:02 pm
oprx
OptimizeRx Co. (NASDAQ: OPRX) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $15.00 price target on the stock.
Low
Report
OptimizeRx Co. (NASDAQ: OPRX) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $15.00 price target on the stock.
4/16
12:02 pm
oprx
OptimizeRx Co. (NASDAQ: OPRX) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $15.00 price target on the stock.
Low
Report
OptimizeRx Co. (NASDAQ: OPRX) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $15.00 price target on the stock.
4/16
11:15 am
oprx
Rating for OPRX
Low
Report
Rating for OPRX
4/16
11:15 am
oprx
Rating for OPRX
Low
Report
Rating for OPRX
4/4
08:04 am
oprx
OptimizeRx Co. (NASDAQ: OPRX) is now covered by analysts at JMP Securities. They set a "market outperform" rating and a $15.00 price target on the stock.
Low
Report
OptimizeRx Co. (NASDAQ: OPRX) is now covered by analysts at JMP Securities. They set a "market outperform" rating and a $15.00 price target on the stock.
4/4
08:04 am
oprx
OptimizeRx Co. (NASDAQ: OPRX) is now covered by analysts at JMP Securities. They set a "market outperform" rating and a $15.00 price target on the stock.
Low
Report
OptimizeRx Co. (NASDAQ: OPRX) is now covered by analysts at JMP Securities. They set a "market outperform" rating and a $15.00 price target on the stock.
4/4
05:00 am
oprx
Rating for OPRX
Low
Report
Rating for OPRX
4/4
05:00 am
oprx
Rating for OPRX
Low
Report
Rating for OPRX
4/1
12:17 pm
oprx
OptimizeRx Co. (NASDAQ: OPRX) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $13.00 price target on the stock.
Low
Report
OptimizeRx Co. (NASDAQ: OPRX) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $13.00 price target on the stock.
4/1
12:17 pm
oprx
OptimizeRx Co. (NASDAQ: OPRX) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $13.00 price target on the stock.
Low
Report
OptimizeRx Co. (NASDAQ: OPRX) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $13.00 price target on the stock.
4/1
11:04 am
oprx
Rating for OPRX
Low
Report
Rating for OPRX
4/1
10:15 am
oprx
OptimizeRx Co. (NASDAQ: OPRX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $17.00 price target on the stock.
Low
Report
OptimizeRx Co. (NASDAQ: OPRX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $17.00 price target on the stock.
4/1
10:15 am
oprx
OptimizeRx Co. (NASDAQ: OPRX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $17.00 price target on the stock.
Low
Report
OptimizeRx Co. (NASDAQ: OPRX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $17.00 price target on the stock.
4/1
09:49 am
oprx
Rating for OPRX
Medium
Report
Rating for OPRX
4/1
09:49 am
oprx
Rating for OPRX
Medium
Report
Rating for OPRX